GenFleet Therapeutics logo

GenFleet Therapeutics jobs and careers

About GenFleet Therapeutics

Dedicated to serving significant unmet medical needs, GenFleet Therapeutics constructs its R&D platform on the basis of disease biology and translational medicine, and researches into latest biological mechanism of cancer pathways, tumor microenvironment and human immunoregulation. GenFleet's rich and diversified pipeline highlights multiple cutting-edge products with novel mechanisms and global intellectual property rights. Through years of endeavor, GenFleet has set up industry-leading capabilities and expertise in developing novel drugs - both small molecules and biologics. Its cutting-edge pipeline includes over 10 products, three of which have progressed into clinical stages. As more projects move into late-stage clinical trials, GenFleet is expected to unravel its blueprint of commercialization during the next 3-5 years.

Founded in 2017 by Lan Jiong and Qiang LU.

Founded
2017
Employees
125
Total funding
$169.4M

Leadership

The top of GenFleet Therapeutics's org chart, with how many people report into each leader.

JL

Jiong Lan

Chief Executive Officer

1 report

DLPhoto of Dong Liu

Dong Liu

Svp/head Of Translational Sciences